P850: THE HUMORAL AND CELLULAR RESPONSE TO SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA AND PRE-MALIGNANT MONOCLONAL GAMMOPATHIES: IMPACT OF OMICRON VARIANT

Bibliographic Details
Published in:	HemaSphere
Main Authors:	P. Storti, V. Marchica, R. Vescovini, V. Franceschi, L. Russo, V. Raimondi, D. Toscani, J. Burroughs Garcia, N. T. Iannozzi, B. Dalla Palma, M. T. Giaimo, L. Notarfranchi, G. Donofrio, N. Giuliani
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000846284.73493.89

Similar Items

Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response
by: Paola Storti, et al.
Published: (2022-12-01)

Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients
by: Vincenzo Raimondi, et al.
Published: (2025-02-01)

Identification of <i>PSMB4</i> and <i>PSMD4</i> as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma
by: Jessica Burroughs Garcia, et al.
Published: (2023-08-01)

A personalized molecular approach in multiple myeloma: the possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitors
by: Vincenzo Raimondi, et al.
Published: (2022-08-01)

Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone disease
by: Vincenzo Raimondi, et al.
Published: (2022-10-01)

P830: IDENTIFICATION OF NOVEL TARGET GENES CORRELATED WITH 1Q21 AMPLIFICATION IN PATIENTS WITH SMOLDERING MYELOMA AND MULTIPLE MYELOMA
by: Nicolas Thomas Iannozzi, et al.
Published: (2023-08-01)

P58 LOW CD38 EXPRESSION BY PLASMA CELLS IN EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA PATIENTS
by: L. Notarfranchi, et al.
Published: (2023-05-01)

Oligosecretory monoclonal gammopathy with renal involvement
by: L V Kozlovskaya, et al.
Published: (2016-12-01)

Kidney injury associated with monoclonal gammopathies: Perspectives on diagnosis and treatment
by: L V Kozlovskaya, et al.
Published: (2015-06-01)

The Monoclonal Gammopathies of Renal Significance
by: Patricia Kleinova, et al.
Published: (2024-08-01)

MONOCLONAL GAMMOPATHY OF CLINICAL SIGNIFICANCE
by: J. Bladé
Published: (2023-05-01)

Monoclonal gammopathies of renal significance
by: Fernando Caravaca-Fontán, et al.
Published: (2017-09-01)

Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy
by: Valentina Marchica, et al.
Published: (2020-07-01)

Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients
by: Vincenzo Raimondi, et al.
Published: (2024-10-01)

The experience of free light chains of immunoglobulin elimination in patients with monoclonal gammopathies
by: E. G. Gromova, et al.
Published: (2019-07-01)

Kidney involvement in monoclonal gammopathies: multidisciplinary approach in oncohematology and nephrology
by: A. V. Smirnov, et al.
Published: (2020-07-01)

CD38 expression by plasma cells in extramedullary multiple myeloma
by: Laura Notarfranchi, et al.
Published: (2023-11-01)

The significance of monoclonal gammopathy of undetermined significance
by: Robert A. Kyle, et al.
Published: (2009-12-01)

Monoclonal gammopathy associated with visceral leishmaniasis
by: Vishal Sharma, et al.

Necrobiotic Xanthogranuloma as Sign of Monoclonal Gammopathy
by: Claudio Conforti, et al.
Published: (2022-10-01)

Recommendations for use of free light chain assay in monoclonal gammopathies
by: Radović Vesna V.
Published: (2010-01-01)

Unusual Cases of Monoclonal Gammopathy of Renal Significance
by: Anjellica Chen, et al.
Published: (2024-01-01)

Prognostic factors in monoclonal gammopathy of undetermined significance
by: Federico Sackmann, et al.
Published: (2008-01-01)

Monoclonal gammopathy of increasing significance: time to screen?
by: Lucia Y. Chen, et al.
Published: (2022-11-01)

Prevalence of MGCS Among Patients With Monoclonal Gammopathies
by: Foteini Theodorakakou, et al.
Published: (2023-06-01)

Pathophysiology and management of monoclonal gammopathy of renal significance
by: Ankur Jain, et al.
Published: (2019-08-01)

Monoclonal gammopathy and myeloproliferative neoplasm molecular diagnostics
by: Stephen E. Langabeer
Published: (2024-10-01)

Monoclonal Gammopathy Presenting Section as Peripheral Neuropathy
by: Vishaka Agarwal, et al.
Published: (2021-04-01)

Scleroderma Associated with Monoclonal Gammopathy of Undetermined Significance
by: Dalya M. M. Abdelmaged, et al.
Published: (2022-12-01)

WCN25-4500 INCIDENCE AND RISK FACTORS FOR MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE (MGRS) IN PATIENTS WITH MONOCLONAL GAMMOPATHY AND RENAL DISEASE
by: Henrique Borges, et al.
Published: (2025-02-01)

The Uncertainty Puzzle of Monoclonal Gammopathy of Renal Significance Without Detectable Clones
by: Chintan V. Shah, et al.
Published: (2023-12-01)

Clinicopathologic characteristics and prognostic analysis of monoclonal gammopathy of renal significance (MGRS) in patients with IgM monoclonal gammopathy: a case series
by: Jing Liu, et al.
Published: (2022-10-01)

Monoclonal gammopathy in WHIM syndrome can mask hypogammaglobulinemia
by: Julia Lew, MD, et al.
Published: (2025-08-01)

Association of Pulmonary Hypertension and Monoclonal Gammopathy of Undetermined Significance
by: Melissa A. Lyle, et al.
Published: (2022-01-01)

Monoclonal gammopathy of renal significance: From bench to bedside
by: Megha Saigal, et al.
Published: (2025-01-01)

Bortezomib maintenance for the treatment of Monoclonal Gammopathy of Renal Significance
by: Holly Lee, et al.
Published: (2019-01-01)

Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China
by: Anping Xu, et al.
Published: (2024-12-01)

Recent advances in C3 glomerulopathy with monoclonal gammopathy
by: Yi-lan Cheng, et al.
Published: (2024-03-01)

Scleredema accompanied by IgG‐λ monoclonal gammopathy
by: Haruka Goto, et al.
Published: (2019-08-01)

Pseudo-monoclonal gammopathy: a report of four cases
by: Majd D. Jawad, et al.
Published: (2017-11-01)